Please login to the form below

Not currently logged in
Email:
Password:

KKR

This page shows the latest KKR news and features for those working in and with pharma, biotech and healthcare.

Investment firm pays $2.8bn for WebMD

Investment firm pays $2.8bn for WebMD

KKR will roll WebMD into its Internet Brands subsidiary, a leading web hosting and software-as-a-service (SaaS) company that works in a number of sectors, including health. ... In the end the process saw WebMD “outreach to more than 100 strategic and

Latest news

  • Bayer sells diabetes division to Panasonic Healthcare Bayer sells diabetes division to Panasonic Healthcare

    Sales of the divested products lines were 909m last year, and Panasonic - which is majority-owned by private equity group KKR - says gaining full control will allow it to improve growth ... We are confident that the sale of our diabetes-care business to

  • GSK plans to sell off older products GSK plans to sell off older products

    conference. Among the firms given the opportunity to view the portfolio are Advent International, Blackstone and KKR, according to Reuters, which indicated the overture was initially revealed by Sky News.

  • KKR acquires clinical trials firm PRA International

    US clinical research organisation (CRO) PRA International has been acquired for an undisclosed sum by global investment firm KKR. ... KKR has a long history in healthcare, having invested more than $9bn in the sector since 1995.

  • Capsugel expands its product portfolio

    The New Jersey company, which Pfizer sold for $2.4bn in 2011 to investment firm KKR, has announced the launched of its Dosage Form Solutions (DFS) unit.

  • Pfizer sells Capsugel business for $2.4bn

    KKR, a leading global investment firm, manages assets through a variety of investment funds and accounts. ... As of December 31, 2010, KKR had $61bn in assets under its management.

More from news
Approximately 2 fully matching, plus 10 partially matching documents found.

Latest Intelligence

  • Deal Watch - May 2017 Deal Watch - May 2017

    go. Barbarians at the Gate. “Barbarians at the Gate” is the title of a book describing the battle for control of RJR Nabisco in 1988 between KKR, a leveraged buyout firm ... KKR won the battle and were accused of being Barbarians for loading RJR

  • Deal Watch table for September 2013 Deal Watch table for September 2013

    700. Gland Pharma / KKR. Acquisition (40 per cent). Indian generics company.

  • Pharma deals during September 2013 Pharma deals during September 2013

    Similar concerns are faced by Indian authorities as KKR has announced its intention to acquire 40 pre cent of generics company Gland Pharma for around $500m.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups
A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...

Infographics